Structure |
Chemical Name |
CAS |
MF |
![ibrutinib iMpurity A](/) |
ibrutinib iMpurity A |
|
|
![Sunitinib iMpurity E](/) |
Sunitinib iMpurity E |
|
|
![Rosuvastatin EP impurity H](/CAS/20210111/GIF/1335110-44-5.gif) |
Rosuvastatin EP impurity H |
1335110-44-5 |
C22H28FN3O6S |
![Saxagliptin Impurity 4 (Deoxy Saxagliptin)](/) |
Saxagliptin Impurity 4 (Deoxy Saxagliptin) |
|
|
![Betamethasone EP Impurity D](/CAS/20180629/GIF/52619-05-3.gif) |
Betamethasone EP Impurity D |
52619-05-3 |
C25H33FO7 |
![Dihydropenicillin F Potassium Salt](/CAS/20211123/GIF/31447-86-6.gif) |
Dihydropenicillin F Potassium Salt |
31447-86-6 |
C14H23KN2O4S |
![Etoricoxib Impurity 7](/CAS/20200611/GIF/646459-39-4.gif) |
Etoricoxib Impurity 7 |
646459-39-4 |
C20H21N3O2S |
![Mupirocin Impurity D](/CAS/20180629/GIF/CB12741867.gif) |
Mupirocin Impurity D |
|
C26H44O9 |
![Phenylephrine EP Impurity D](/CAS/20180629/GIF/1367567-95-0.gif) |
Phenylephrine EP Impurity D |
1367567-95-0 |
C16H19NO2 |
![Verapamil Impurity O](/CAS/20180629/GIF/959011-16-6.gif) |
Verapamil Impurity O |
959011-16-6 |
C27H38N2O4 |
![1,1′-[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol hydrochloride](/CAS/20211123/GIF/1486464-40-7.gif) |
1,1′-[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol hydrochloride |
1486464-40-7 |
C27H42ClNO6 |
![4'-FLUOROCYCLOPROPANECARBOXANILIDE](/CAS/20180629/GIF/2354-89-4.gif) |
4'-FLUOROCYCLOPROPANECARBOXANILIDE |
2354-89-4 |
C10H10FNO |
![(Z)-2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetic acid](/CAS/GIF/102507-85-7.gif) |
(Z)-2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetic acid |
102507-85-7 |
C9H11N3O5S |
![Cefaclor EP IMpurity](/) |
Cefaclor EP IMpurity |
|
|
![Linagliptin Impurity F](/CAS/20180808/GIF/1673546-62-7.gif) |
Linagliptin Impurity F |
1673546-62-7 |
C27H27F3N8O3 |
![Parecoxib Impurity D](/) |
Parecoxib Impurity D |
|
|
![Parecoxib Impurity I](/) |
Parecoxib Impurity I |
|
|
![Lenvatinib Impurity d](/CAS/20180808/GIF/417717-04-5.gif) |
Lenvatinib Impurity d |
417717-04-5 |
C20H17ClN4O4 |
![4-bromo-3-(hydroxymethyl)phenol](/CAS/GIF/2737-20-4.gif) |
4-bromo-3-(hydroxymethyl)phenol |
2737-20-4 |
C7H7BrO2 |
![4-(4-Bromo-3-formyl-phenoxy)-benzonitrile](/CAS/GIF/906673-54-9.gif) |
4-(4-Bromo-3-formyl-phenoxy)-benzonitrile |
906673-54-9 |
C14H8BrNO2 |
![Linagliptin Impurity I](/) |
Linagliptin Impurity I |
|
|
![1H-Pyrrole-3-carbonitrile,5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)-](/CAS/20180629/GIF/1807642-39-2.gif) |
1H-Pyrrole-3-carbonitrile,5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- |
1807642-39-2 |
C16H10FN3O2S |
![4-amino-1-[(2RS)-2-(2,4-difluorophenyl)-2-hydroxy-3(1H-
1,2,4-triazol-1-yl)propyl]-4H-1,2,4-triazolium](/CAS/20180629/GIF/749821-19-0.gif) |
4-amino-1-[(2RS)-2-(2,4-difluorophenyl)-2-hydroxy-3(1H-
1,2,4-triazol-1-yl)propyl]-4H-1,2,4-triazolium |
749821-19-0 |
C13H14F2N7O+ |
![Canagliflozin Defluoro Impurity](/) |
Canagliflozin Defluoro Impurity |
|
|
![Dapagliflozin Impurity 6](/) |
Dapagliflozin Impurity 6 |
|
|
![Imatinib Impurity 7](/CAS/20180808/GIF/581076-64-4.gif) |
Imatinib Impurity 7 |
581076-64-4 |
C8H12N4 |
![Nilotinib Impurity 1](/CAS/20210111/GIF/641571-05-3.gif) |
Nilotinib Impurity 1 |
641571-05-3 |
C28H22F3N7O |
![Riociguat Impurtiy 1](/) |
Riociguat Impurtiy 1 |
|
|
![Riociguat Impurtiy 6](/CAS/20180808/GIF/1702271-98-4.gif) |
Riociguat Impurtiy 6 |
1702271-98-4 |
C18H17FN8 |
![Brimonidine Impurity E](/CAS/20180808/GIF/168329-48-4.gif) |
Brimonidine Impurity E |
168329-48-4 |
C9H8BrN5 |
![Dapagliflozin Impurity G](/) |
Dapagliflozin Impurity G |
|
|
![Dapoxetine Impurity B](/) |
Dapoxetine Impurity B |
|
|
![Fesoterodine Diol Dimer](/CAS/20180808/GIF/1428856-45-4.gif) |
Fesoterodine Diol Dimer |
1428856-45-4 |
C44H60N2O3 |
![Gimeracil Impurity](/CAS/20180808/GIF/17902-24-8.gif) |
Gimeracil Impurity |
17902-24-8 |
C8H9ClN2O3 |
![Pramipexole Impurity H](/) |
Pramipexole Impurity H |
|
|
![Rivaroxaban Impurity H](/CAS/20200515/GIF/1807455-76-0.gif) |
Rivaroxaban Impurity H |
1807455-76-0 |
C25H24Cl2N4O6S2 |
![Vonoprazan impurity A](/) |
Vonoprazan impurity A |
|
|
![5-ethyl 3-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate](/CAS/20200119/GIF/2170716-02-4.gif) |
5-ethyl 3-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
2170716-02-4 |
C22H29ClN2O5 |
![Ibrutinib impurity D](/) |
Ibrutinib impurity D |
|
|
![Mupirocin impurity A](/CAS/20180629/GIF/CB13053659.gif) |
Mupirocin impurity A |
|
C26H44O9 |
![FG-4592 intermediate7](/CAS/20200611/GIF/1509958-19-3.gif) |
FG-4592 intermediate7 |
1509958-19-3 |
C20H20N2O4 |
![Milnacipran Impurity 13](/CAS/20211123/GIF/710339-49-4.gif) |
Milnacipran Impurity 13 |
710339-49-4 |
C12H16NO+ |
![Urapidil Impurity A](/) |
Urapidil Impurity A |
|
|
![Tofacitinib Impurity I](/) |
Tofacitinib Impurity I |
|
|
![N-(3-chloro-4-fluorophenyl)-6 ,7-dimethoxyquinazolin-4-amine](/CAS/20200515/GIF/153437-78-6.gif) |
N-(3-chloro-4-fluorophenyl)-6 ,7-dimethoxyquinazolin-4-amine |
153437-78-6 |
C16H13ClFN3O2 |
![Itopride Impurity C](/CAS/20200515/GIF/141996-97-6.gif) |
Itopride Impurity C |
141996-97-6 |
C19H24N2O4 |
![Mirabegron Impurity](/CAS/20180808/GIF/1796931-48-0.gif) |
Mirabegron Impurity |
1796931-48-0 |
C21H24N4O2S |
![FAMOTIDINE RELATED COMPOUND B](/CAS/GIF/89268-62-2.gif) |
FAMOTIDINE RELATED COMPOUND B |
89268-62-2 |
C16H23N11O2S5 |
![TIZOXANIDE GLUCURONIDE, SODIUM SALT](/CAS/GIF/221287-83-8.gif) |
TIZOXANIDE GLUCURONIDE, SODIUM SALT |
221287-83-8 |
C16H14N3NaO10S |
![Sugammadex sodium Impurity 50](/) |
Sugammadex sodium Impurity 50 |
|
|
![Cabozantinib impurity 39](/) |
Cabozantinib impurity 39 |
|
|
![Cabozantinib impurity 53](/) |
Cabozantinib impurity 53 |
|
|
![1-(2-chloro-2-(2,4-difluorophenyl)ethyl)-1H-1,2,4-triazole](/CAS/20210111/GIF/206050-24-0.gif) |
1-(2-chloro-2-(2,4-difluorophenyl)ethyl)-1H-1,2,4-triazole |
206050-24-0 |
C10H8ClF2N3 |
![methyl 1-phenylethanesulfonate](/CAS/20210111/GIF/883835-57-2.gif) |
methyl 1-phenylethanesulfonate |
883835-57-2 |
C9H12O3S |
![Doxofylline Impurity 22](/) |
Doxofylline Impurity 22 |
|
|
![Dapoxetine impurity 61](/) |
Dapoxetine impurity 61 |
|
|
![Dapoxetine impurity 55](/) |
Dapoxetine impurity 55 |
|
|
![1-METHYLBIGUANIDE SULPHATE](/CAS/GIF/1609-00-3.gif) |
1-METHYLBIGUANIDE SULPHATE |
1609-00-3 |
C3H9N5 |
![1-(3,5-DIHYDROXYPHENYL)-2-[(1,1-DIMETHYLETHYL)AMINO]-ETHANONE, HYDROCHLORIDE](/StructureFile/ChemBookStructure8/GIF/CB2752536.gif) |
1-(3,5-DIHYDROXYPHENYL)-2-[(1,1-DIMETHYLETHYL)AMINO]-ETHANONE, HYDROCHLORIDE |
1246815-70-2 |
C12H18ClNO3 |
![4-(((2R,3S,4R,5R,6R)-6-(Benzyloxy)-3-((diphenoxyphosphoryl)oxy)-4-(tetradecanoyloxy)-5-((S)-3-(tetradecanoyloxy)tetradecanaMido)tetrahydro-2H-pyran-2-yl)Methoxy)-4-oxobutanoic acid](/CAS/GIF/110611-91-1.gif) |
4-(((2R,3S,4R,5R,6R)-6-(Benzyloxy)-3-((diphenoxyphosphoryl)oxy)-4-(tetradecanoyloxy)-5-((S)-3-(tetradecanoyloxy)tetradecanaMido)tetrahydro-2H-pyran-2-yl)Methoxy)-4-oxobutanoic acid |
110611-91-1 |
C71H110NO15P |
![Oxacillin Impurity H](/) |
Oxacillin Impurity H |
|
|
![(2S,3R)-3-(6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol](/) |
(2S,3R)-3-(6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
|
|
![PeraMpanel](/CAS/20210111/GIF/380918-54-7.gif) |
PeraMpanel |
380918-54-7 |
C23H15N3O |
![Empagliflozin Impurity 79](/) |
Empagliflozin Impurity 79 |
|
|
![Empagliflozin Impurity 89](/CAS/20211123/GIF/2452301-32-3.gif) |
Empagliflozin Impurity 89 |
2452301-32-3 |
C23H25ClO7 |
![Levocarnitine Impurity F](/CAS/20211123/GIF/6490-19-3.gif) |
Levocarnitine Impurity F |
6490-19-3 |
C7H17ClN2O2 |
![4,4-dimethyl-2-(2-phenylpropan-2-yl)oxazo‐ line](/CAS/20210111/GIF/874895-87-1.gif) |
4,4-dimethyl-2-(2-phenylpropan-2-yl)oxazo‐ line |
874895-87-1 |
C14H19NO |
![Formoterol Impurity 4](/) |
Formoterol Impurity 4 |
|
|
![Roxadustat-001](/CAS/20211123/GIF/319-57-3.gif) |
Roxadustat-001 |
319-57-3 |
C8H5BF4N2O2 |
![Ornidazole Impurity 24](/) |
Ornidazole Impurity 24 |
|
|
![Olanzapine impurity ANB](/) |
Olanzapine impurity ANB |
|
|
![Pitavastatin Impurity 75](/) |
Pitavastatin Impurity 75 |
|
|
![Febuxostat Impurity 100](/) |
Febuxostat Impurity 100 |
|
|
![Febuxostat Impurity 101](/) |
Febuxostat Impurity 101 |
|
|
![Febuxostat Impurity 105](/) |
Febuxostat Impurity 105 |
|
|
![(S)-10-amino-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid](/) |
(S)-10-amino-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
|
|
![Ticagrelor Impurity 129](/CAS/20210111/GIF/1381841-36-6.gif) |
Ticagrelor Impurity 129 |
1381841-36-6 |
C15H19NO3 |
![Benzoic acid, 2-hydroxy-3-(2-phenyldiazenyl)-](/CAS/20200611/GIF/136819-59-5.gif) |
Benzoic acid, 2-hydroxy-3-(2-phenyldiazenyl)- |
136819-59-5 |
C13H10N2O3 |
![5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, 5-oxide, (6R,7R)- (9CI)](/CAS/20200611/GIF/97466-28-9.gif) |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, 5-oxide, (6R,7R)- (9CI) |
97466-28-9 |
C18H18N8O8S3 |
![1,3-Benzenediamine, 4-methyl-N3-[4-methyl-6-(3-pyridinyl)-2-pyrimidinyl]-](/CAS/20200611/GIF/1032314-73-0.gif) |
1,3-Benzenediamine, 4-methyl-N3-[4-methyl-6-(3-pyridinyl)-2-pyrimidinyl]- |
1032314-73-0 |
C17H17N5 |
![5-methoxy-1-methyl-1H-benzo[d]imidazole-2-sulfonic acid](/) |
5-methoxy-1-methyl-1H-benzo[d]imidazole-2-sulfonic acid |
|
|
![Teneligliptin Impurity 17](/) |
Teneligliptin Impurity 17 |
|
|
![1(3H)-Isobenzofuranone, 3-(1-methylpropyl)-](/CAS/20210111/GIF/261783-87-3.gif) |
1(3H)-Isobenzofuranone, 3-(1-methylpropyl)- |
261783-87-3 |
C12H14O2 |
![Carbamic acid, N-[(1R)-2-[5-(2-fluoro-3-hydroxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]-, 1,1-dimethylethyl ester](/CAS/20210111/GIF/1062642-68-5.gif) |
Carbamic acid, N-[(1R)-2-[5-(2-fluoro-3-hydroxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]-, 1,1-dimethylethyl ester |
1062642-68-5 |
C32H30F5N3O5 |
![2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5S)-](/CAS/20200611/GIF/2514942-86-8.gif) |
2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5S)- |
2514942-86-8 |
C13H15NO4 |
![6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-3-oxo-, (5S,6E)-](/CAS/20200611/GIF/1803023-43-9.gif) |
6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-3-oxo-, (5S,6E)- |
1803023-43-9 |
C22H26FN3O6S |
![NA](/) |
NA |
|
|
![1-Pyrrolidinecarboxamide, N-[5-[(2S)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3R)-](/CAS/20210111/GIF/2409590-08-3.gif) |
1-Pyrrolidinecarboxamide, N-[5-[(2S)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3R)- |
2409590-08-3 |
C21H22F2N6O2 |
![Sertraline Impurity 20](/CAS/20210111/GIF/1498236-91-1.gif) |
Sertraline Impurity 20 |
1498236-91-1 |
C16H14Cl2O |
![Budesonide Impurity 21](/) |
Budesonide Impurity 21 |
|
|
![2H-3-Benzazepin-2-one, 3-(3-bromopropyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-](/CAS/20210111/GIF/1192174-72-3.gif) |
2H-3-Benzazepin-2-one, 3-(3-bromopropyl)-1,3,4,5-tetrahydro-7,8-dimethoxy- |
1192174-72-3 |
C15H20BrNO3 |
![1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-nitro-, ethyl ester, (3R,4R,5S)-](/CAS/20210111/GIF/949164-64-1.gif) |
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-nitro-, ethyl ester, (3R,4R,5S)- |
949164-64-1 |
C16H26N2O6 |
![Peramivir Impurity 55](/) |
Peramivir Impurity 55 |
|
|
![Peramivir Impurity 60](/) |
Peramivir Impurity 60 |
|
|
![Hexanoic acid, 3-(hydroxymethyl)-, methyl ester, (3R)-](/CAS/20210111/GIF/2408196-94-9.gif) |
Hexanoic acid, 3-(hydroxymethyl)-, methyl ester, (3R)- |
2408196-94-9 |
C8H16O3 |
![Loratadine EP Impurity L](/) |
Loratadine EP Impurity L |
|
|
![Pregna-1,4-dien-3-one, 21-(acetyloxy)-11,17,20-trihydroxy-6-methyl-, (6α,11β)- (9CI)](/CAS/20211123/GIF/151003-82-6.gif) |
Pregna-1,4-dien-3-one, 21-(acetyloxy)-11,17,20-trihydroxy-6-methyl-, (6α,11β)- (9CI) |
151003-82-6 |
C24H34O6 |
![3-(4-TRIFLUOROMETHYL-PHENYL)-PROPAN-1-OL](/CAS/GIF/180635-74-9.gif) |
3-(4-TRIFLUOROMETHYL-PHENYL)-PROPAN-1-OL |
180635-74-9 |
C10H11F3O |
![(1R,2R)-2-(3-((5-acetoxypentyl)oxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium](/) |
(1R,2R)-2-(3-((5-acetoxypentyl)oxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium |
|
|
![(E)-2-CYANO-5-METHYL-HEX-2-ENOIC ACID METHYL ESTER](/CAS/GIF/96914-67-9.gif) |
(E)-2-CYANO-5-METHYL-HEX-2-ENOIC ACID METHYL ESTER |
96914-67-9 |
C9H13NO2 |